Strong synergy is seen in neuronal, renal, breast, lung, and haematopoietic cancer cells harboring abnormalities in PTEN, VHL, LKB1, Her2, or KRAS. The gene discussed is ERBB2; the disease is hematopoietic and lymphoid cell neoplasm.